Literature DB >> 15619627

Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue.

Kazuhiko Yamada1, Koji Yazawa, Akira Shimizu, Takehiro Iwanaga, Yosuke Hisashi, Matthew Nuhn, Patricia O'Malley, Shuji Nobori, Parsia A Vagefi, Clive Patience, Jay Fishman, David K C Cooper, Robert J Hawley, Julia Greenstein, Henk-Jan Schuurman, Michel Awwad, Megan Sykes, David H Sachs.   

Abstract

The use of animal organs could potentially alleviate the critical worldwide shortage of donor organs for clinical transplantation. Because of the strong immune response to xenografts, success will probably depend upon new strategies of immune suppression and induction of tolerance. Here we report our initial results using alpha-1,3-galactosyltransferase knockout (GalT-KO) donors and a tolerance induction approach. We have achieved life-supporting pig-to-baboon renal xenograft survivals of up to 83 d with normal creatinine levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619627     DOI: 10.1038/nm1172

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  197 in total

1.  Pathologic characteristics of transplanted kidney xenografts.

Authors:  Akira Shimizu; Kazuhiko Yamada; Simon C Robson; David H Sachs; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2011-11-23       Impact factor: 10.121

2.  Prolonged survival of GalT-KO swine skin on baboons.

Authors:  Joshua Weiner; Kazuhiko Yamada; Yoshinori Ishikawa; Shannon Moran; Justin Etter; Akira Shimizu; Rex Neal Smith; David H Sachs
Journal:  Xenotransplantation       Date:  2010 Mar-Apr       Impact factor: 3.907

Review 3.  CD47 in xenograft rejection and tolerance induction.

Authors:  Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

4.  Retroviral restriction factors and infectious risk in xenotransplantation.

Authors:  Y Meije; R R Tönjes; J A Fishman
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

5.  Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.

Authors:  C C Lin; M Ezzelarab; R Shapiro; B Ekser; C Long; H Hara; G Echeverri; C Torres; H Watanabe; D Ayares; A Dorling; D K C Cooper
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

6.  Xenotransplantation makes a comeback.

Authors:  Jeffrey M Perkel
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

7.  Role of Intrinsic Factors in the Growth of Transplanted Organs Following Transplantation.

Authors:  Jigesh A Shah; Tatsu Tanabe; Kazuhiko Yamada
Journal:  J Immunobiol       Date:  2017-05-02

8.  Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment.

Authors:  Fan Liang; Isaac Wamala; Joseph Scalea; Aseda Tena; Taylor Cormack; Shannon Pratts; Raimon Duran-Struuck; Nahel Elias; Martin Hertl; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

9.  Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.

Authors:  Christopher J Rivard; Tatsu Tanabe; Miguel A Lanaspa; Hironosuke Watanabe; Shunichiro Nomura; Ana Andres-Hernando; Krystle Garth; Mitsuhiro Sekijima; Takuji Ishimoto; Yuichi Ariyoshi; Gabriela E Garcia; Jigesh Shah; Boyd Lennan; Masayuki Tasaki; Thomas Pomposelli; Akira Shimizu; David H Sachs; Richard J Johnson; Kazuhiko Yamada
Journal:  Transpl Int       Date:  2018-06-05       Impact factor: 3.782

10.  How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Authors:  Marco Carbone; Jan Lerut; James Neuberger
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.